July 9, 2008
Investment Value of Top 10 North American Life Science Projects Drops 34% to $2.9 Billion in 2008, an Industrial Info News Alert
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- An analysis of the top 10 North American Pharmaceutical & Biotech capital projects currently scheduled to begin construction in 2008 reveals a cumulative total investment value (TIV) of $2.9 billion. Although the figure is impressive, it is a 34% drop compared with the same analysis of last year's top 10 projects, which totaled $4.4 billion. Shire PLC's (LSE:SHP) (Chineham, Basingstoke) Wayne, Pennsylvania, office remains at the top for 2008, followed by Massachusetts where Alexandria Real Estate Equities Incorporated (NYSE:ARE) (Pasadena, California) is in a joint venture to build a 250,000-square-foot facility.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=135201, or browse other breaking industrial news stories at www.industrialinfo.com.Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information send inquiries to [email protected] or visit us at www.industrialinfo.com.
Related News Articles
Bio Buzz: Life Science Investment Spurs Bipartisanship at its Best at BIO 2008
Pharma-Bio Capital Prognosis: Signs of Life with $12 Billion in Active Grassroot Projects
Construction Begins on $254 Million Cardiovascular Research Institute for UCSF
Contact: Joe Govreau 713-783-5147
SOURCE: Industrial Info Resources